by EmpathiCSubstanceS | Apr 25, 2021 | MDMA Sassafras Molly
Psychedelic pharmaceutical company MindMed is set to conduct a novel Phase 1 clinical trial exploring the subjective effects of combining LSD with MDMA. The primary goal of the prospective study is to investigate whether MDMA, a drug known to induce feelings of...
by EmpathiCSubstanceS | Apr 25, 2021 | Cannabis Marijuana, Cluster Headaches
An incredible, first-of-its-kind trial testing the pain-killing properties of LSD microdoses has delivered the compelling suggestion that tiny, non-psychedelic doses of this infamous drug could serve as an effective analgesic. Back in the 1960s, during the original...
by EmpathiCSubstanceS | Apr 25, 2021 | Addiction, Cannabis Marijuana
Research from Washington State University (WSU), and published in The Journal of Affective Disorders, is reporting some people find their symptoms of obsessive-compulsive disorder (OCD) dramatically drop after smoking cannabis. The study suggests the improvements may...
by EmpathiCSubstanceS | Apr 25, 2021 | Cannabis Marijuana
A new study is presenting the first published data from preliminary human trials investigating the effect of psilocybin-assisted psychotherapy to treat major depressive disorder (MDD). The incredibly positive results have been described as just a “taste of things to...
by EmpathiCSubstanceS | Apr 25, 2021 | Psychedelic Medicine
While the 2020 US election has turned into a nail-biter with a deeply partisan divide splitting the country with razor-thin margins, a broad array of ballot measures relating to drug reform have turned out to be some of the only things Americans seem to agree on. A...
